Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04307212 · ClinicalTrials.gov registry record · NA
How Exercise Signals Health Responses
A NA study, sponsored by USDA Grand Forks Human Nutrition Research Center.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT04307212: Completed NA study, sponsored by USDA Grand Forks Human Nutrition Research Center.
NCT04307212 is a NA study that has completed, run by USDA Grand Forks Human Nutrition Research Center. The registered enrollment target is 41 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04307212, a NA study, has completed, sponsored by USDA Grand Forks Human Nutrition Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
The purpose of this research is to determine the blood signals that promote health and well-being in response to exercise at different intensities.
Primary Outcome
Blood samples collected during exercise will be analyzed for the concentration of plasma myokines including Brain Derived Neurotropic Factor (BDNF), Secreted Protein Acidic and Rich in Cysteine (SPARC), Leukemia Inhibitory Factor (LIF), Interleukin (IL) 15, IL-6, Myostatin, Irisin, Follistatin-like 1 (FSTL-1), Fibroblast Growth Factor 21 (FGF-21), IL-4, IL-7 receptor agonist (ra), IL-7, beta-aminoisobutyric acid (BAIBA), IL-1ra, Growth Differentiation Factor (GDF) 8, Insulin-Like Growth Factor-1
Interventions
- OTHER 50% heart rate reserve (HRR) low intensity exercise
- OTHER 75% HRR moderate intensity exercise
- OTHER Control no exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2020-01-10 |
| Est. Completion | 2023-09-12 |
| Phase | NA |
What the finished NCT04307212 record still lists
NCT04307212 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 3 interventions - of which 50% heart rate reserve (HRR) low intensity exercise is the first listed.
NCT04307212 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04307212 about?
NCT04307212 is a clinical study titled "How Exercise Signals Health Responses". The purpose of this research is to determine the blood signals that promote health and well-being in response to exercise at different intensities.
What is the current status of trial NCT04307212?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2020-01-10. Estimated completion is 2023-09-12.
What interventions are being tested in trial NCT04307212?
The interventions under investigation include: 50% heart rate reserve (HRR) low intensity exercise (OTHER), 75% HRR moderate intensity exercise (OTHER), Control no exercise (OTHER).
Who is sponsoring clinical trial NCT04307212?
This trial is sponsored by USDA Grand Forks Human Nutrition Research Center, which has 57 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04307212's enrollment target sits among peer trials
41 1446th of 2000 higher than 554 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI